Track topics on Twitter Track topics that are important to you
Background. With the increasing use of thyroid ultrasound, the recognition of thyroid nodules in a large proportion of apparently healthy subjects has become common. Because also the papillary thyroid microcarcinomas (PTMC) are being increasingly discovered, it is important to ascertain whether PTMC may exhibit heterogenous clinical features, associated with different aggressiveness. Aim. We retrospectively examined 122 subjects (98 female, 80.3%, and 24 males) with thyroid cancer to find potential clinical and pathological findings that could be predictive of clinically aggressive behavior. Results. 20 of the 31 patients with true incidental cancer (64.5%) in comparison to 20 of the 91 patients with non incidental cancer (21.9%) had a diameter <10 mm, and this difference was statistically significant (p <0.0001). There was a statistically significant association between size and invasiveness because 19.3% of invasive cancers were smaller than 10 mm whereas 44.6% of non invasive cancers were smaller than 10 mm (p=0.005). The relationship between incidental discovery and invasiveness was also evaluated, but the proportion of incidental invasive cancer (19.3%) was not significantly different than that of incidental non invasive cancer (30.8%). In the multivariate analysis, only size <10 mm (OR=0.35, p=0.013) and papillary vs. other histotypes (OR=0.35, p=0.04) were statistically significant protective factors against invasiveness. Conclusions. (i.) Incidentally discovered thyroid cancers are more frequently microcarcinomas; (ii.) there appears to be no difference in terms of invasive behavior between the incidental and non incidental thyroid cancer; (iii.) smaller tumor size emerges as a protective factor.
Section of Internal Medicine, Endocrinology, Andrology, and Metabolic Disease, University of Bari "Aldo Moro", Bari, Italy. firstname.lastname@example.org.
This article was published in the following journal.
Name: Journal of endocrinological investigation
The vertiginous expansion of knowledge about endocrinology brings some caveats to the clinical practice. For instance, differentiated thyroid cancer, which was a relatively uncommon neoplasia 40 years...
Introduction The incidence of thyroid cancer has increased worldwide. The country where the incidence has increased most is South Korea. The goal of this study is to understand the magnitude of associ...
Papillary thyroid cancer is often described as the "good cancer" because of its treatability and relatively favorable survival rates. We sought to characterize the thoughts of papillary thyroid cancer...
The increase in incidence of thyroid cancer during the last decades without concomitant rise in mortality may reflect the growing detection of indolent forms of thyroid cancer, and may have fueled unn...
To our knowledge, thyroid cancer incidence is increasing faster than any other cancer type and is currently the fifth most common cancer among women. While this rise is likely multifactorial, there ha...
RATIONALE: Gathering information about patients with thyroid cancer or thyroid nodules may help the study of thyroid cancer in the future. PURPOSE: This study is gathering information and...
To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.
Human thyroglobulin (Tg) is the most sensitive biochemical marker for recurrence of differentiated cancer (DTC), especially after the complete removal of thyroid tissue through surgery and...
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for...
Clinical and subclinical thyroid disease is usually used to describe patients with mild symptoms correlated to hyperthyroid or hypothyroid state. Therapeutic decision for clinical and subc...
An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.
Tumors or cancer of the THYROID GLAND.
Defective development of the THYROID GLAND. This concept includes thyroid agenesis (aplasia), hypoplasia, or an ectopic gland. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.
Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.
A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)
The thyroid is a butterfly-shaped gland in the neck, just above thecollarbone and is an endocrine gland that make hormones. These Thyroid hormones control the rate of many activities in the body, including how fast the body burns calories and how fast th...
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...